75N91026R00001_HHS - JOFOC_Redacted.pdf

sources on the same cancer to promote and advance best practices related to quality improvement, recommendations processing different types of incomplete cancer records, and the use of emerging bioinformatics technologies and data systems; (3) participate in collaborative efforts that use high quality population-based cancer registry data and prepare technical reports. Areas of focus include, but are not limited to, Data Use and Quality, Research Metrics and Methods, and Social and Economic determinants of disease; and

(4) build and enhance ties with cancer surveillance organizations worldwide, improve the worldwide availability of good cancer registry-centered surveillance data, strengthen regional cancer surveillance networks, and improve resource sharing among high quality cancer surveillance systems tailored to low resource environments, and ensure comparability and utility of American data in resolving large scale cancer issues and harmonization of data standards.

4. Statutory Authority Cited and Rationale:

RFO - FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. Authority: 41 U.S.C. 3304(a)(1).

Special Considerations for Certain Contract Extensions or Bridge Contracts:

Not Applicab

Responses Were Received:

Sources Expressing Interest:

Actions to Foster Competition for Future, Similar Requirements: Based on the acquisition history presented for this ongoing Programmatic requirement, it is anticipated that a subsequent acquisition likely will be needed. As a result, the Government will continue to assess the marketplace and monitor the availability of alternative sources capable of performing the required services through market research, outreach, and review of responses to notices published on SAM.gov. , the NCI’s specialized scientific program manager staff will continue to engage in communications with the cancer surveillance community to discern if there are any other organizations with a focus on developing and applying population-based cancer registration and surveillance research techniques to studies of defined population groups. In good faith, the Government will seek to compete future acquisitions for this on-going requirement to the maximum extent practicable should future market research identify additional responsible sources with the requisite expertise, capacity, and infrastructure to meet the Government’s requirements. Any future procurements will continue to be supported by appropriate and applicable notices posted on the federal-wide point of entry for contracting opportunities, pursuant to RFO FAR Part 5 Publicizing Contract Actions.

7. Market Research:

The stated Division, in conjunction with Subject Matter Experts, conducted independent market research through review of prior acquisition history, assessment of the current cancer surveillance marketplace, and reliance on extensive programmatic knowledge and experience with organizations engaged in cancer registry standards, operations, and surveillance support. This market research included evaluation of whether any other organizations possess the governance structure, registry participation, technical expertise, and infrastructure necessary to perform the required services.

Market research did not identify any capable of performing the full scope of the requirement. Based on this market research, it was determined that the intended Contractor remains the only responsible source capable of performing this on-going requirement. This is due to its established collaborative professional organization with the expertise, resources, and infrastructure necessary to coordinate population-based cancer registries, develop and maintain national standards, and support registry operations at a national scale.

The Contracting Officer determined, based upon reviewing the available acquisition history for this on-going requirement, that posting a Sources Sought notice for this requirement would not yield a different outcome than had been provided through independent market research conducted, as documented here and in the HHS FY26 Streamlined Market Research Report. The Procurement Administrative Lead Time (PALT) that would have been required for the notice was distributed to downstream acquisition activities in the project milestone schedule for this requirement.

A presolicitation notice of intent to award a sole-source contract posted on SAM.gov in accordance with RFO - FAR requirements .

8. Procurement History:

In September of 2000, the National Cancer Institute entered into a 3-year cost-reimbursement / completion contract with NAACCR to provide technical support for cancer surveillance activities. The contract N02-PC- 05030 awarded September 30, 2000, was negotiated at $1,673,000 and was funded annually.

A 5-year follow-on acquisition (HHSN261200444001C) with NAACCR by other than full and open competition was awarded July 16, 2004, negotiated at $2,417,000.

A 5-year follow-on acquisition (HHSN261200900015C) with NAACCR by other than full and open competition was awarded July 1, 2009, negotiated at $3,510,000.

A 7-year follow-on acquisition (HHSN261201400004I) with NAACCR by other than full and open competition was awarded July 1, 2014, negotiated at $9,900,000.

A 5-year follow on acquisition (75N91021D00018) with NAACCR by other than full and open competition was awarded July 1, 2021, negotiated at $16,000,000. It expires June 30, 2026.

9. Additional Information or Other Facts:

None.

10. Technical or Requirements Program Management Certification: I certify that the supporting data under my cognizance which are included in the justification are accurate and complete to the best of my knowledge and belief.

11. Fair and Reasonable Price Determination: As the Contracting Officer, I hereby determine that the anticipated price to the Government for this contract action will be fair and reasonable.

This determination will be made using the following: cost analysis price analysis cost realism market pricing historical pricing other:

12. Contracting Officer (CO) Certification and Determination: I hereby certify that this justification is accurate and complete to the best of my knowledge and belief. And, based upon the foregoing, I also determine that using a sole-source contract is in the best interest of the NIH, NCI, DCCPS, SRP, Office of the Associate Director.

Catherine A. Muir Contracting Officer; OALM, OD, NIH Signature & Date:

ELEVATED REVIEWS & APPROVALS

13. : I reviewed this justification find that it adequately supports other than full and open competition.

Signature & Date:

Head of the Contracting Activity (HCA) Review and Approval: I reviewed this justification and find that it adequately supports other than full and open competition.

Olga Acosta

Head of the Contracting Activity, NIH Signature & Date:

CATHERI

NE A.

MUIR -S

Digitally signed by CATHERINE

A. MUIR -S

Date: 2026.03.25 07:12:01 -04'00'

RASHIDA

S. HOGG

FEREBEE

-S

Digitally signed by RASHIDA S.

HOGG

FEREBEE -S

Date: 2026.05.15 10:24:25 -04'00'

TIFFANY

D.

CHADWIC

K -S

Digitally signed by TIFFANY D.

CHADWICK -S

Date:

2026.05.21 14:01:37 -04'00'

KATHRYN

M.

PARTIN -S

Digitally signed by KATHRYN M.

PARTIN -S

Date: 2026.05.22 08:23:14 -04'00'